(Q37016566)

17 August 2017

1 reference

title

18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review (English)

1 reference

positron emission tomography

17 August 2017

1 reference

1 reference

1 reference

Yee C Ung

1

1 reference

17 August 2017

Donna E Maziak

2

1 reference

17 August 2017

Jessica A Vanderveen

3

1 reference

17 August 2017

Christopher A Smith

4

1 reference

17 August 2017

Karen Gulenchyn

5

1 reference

17 August 2017

Christina Lacchetti

6

1 reference

17 August 2017

William K Evans

7

1 reference

17 August 2017

Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care

8

1 reference

17 August 2017

language of work or name

English

0 references

publication date

27 November 2007

1 reference

Journal of the National Cancer Institute

17 August 2017

published in

1 reference

17 August 2017

volume

99

1 reference

17 August 2017

issue

23

1 reference

17 August 2017

page(s)

1753-1767

1 reference

From PET detectors to PET scanners

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Lesion detectability and clinical effectiveness of dual-head coincidence gamma camera imaging in comparison with dedicated PET systems in tumour patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Performance comparison of two dual-head coincidence cameras of the first and latest generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Positron emission tomography: a review of basic principles, scanner design and performance, and current systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Positron emission tomography in limited-stage small-cell lung cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Impact of [18F]FDG-PET on the primary staging of small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

FDG-PET imaging and the diagnosis of non-small cell lung cancer in a region of high histoplasmosis prevalence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Validation of FDG positron emission tomography for differentiation of unknown pulmonary lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Value of positron emission tomography for lung cancer staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Traditional versus up-front [18F] fluorodeoxyglucose-positron emission tomography staging of non-small-cell lung cancer: a Dutch cooperative randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Lymph node staging in lung cancer using [18F]FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

FDG-PET in staging lung cancer: how does it change the algorithm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Staging non-small cell lung cancer with whole-body PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Factors associated with false-positive staging of lung cancer by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Mediastinal lymph node sampling following positron emission tomography with fluorodeoxyglucose imaging in lung cancer staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Advantages of positron emission tomography over computed tomography in mediastinal staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: powerful correlation with survival and high impact on treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Are health technology assessments a reliable tool in th analysis of the clinical value of PET in oncology? Who audits the auditors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

Selective use of PET scan in the preoperative staging of NSCLC

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM232

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJM232

1 reference

17 August 2017

1 reference